Relevant bibliographies by topics / Health and diseases

Academic literature on the topic 'Health and diseases'

Author: Grafiati
Published: 4 June 2021
Last updated: 30 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Health and diseases.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Health and diseases"

1

Li, Junxia, Lijun Chen, Changhui Zhou, Yifan Bai, Ruiyan Zhao, Jinge Zhang, Xiaoqiao Xu, Xingyi Ge, and Ye Qiu. "Insight to Pyroptosis in Viral Infectious Diseases." Health 13, no. 05 (2021): 574–90. http://dx.doi.org/10.4236/health.2021.135043.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wang, Ying. "The Occupational Diseases and Countermeasures of Pianists." Health 11, no. 09 (2019): 1147–51. http://dx.doi.org/10.4236/health.2019.119088.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gonzalez-Medina, Diego, and Quan V. Le. "Infectious diseases and interpersonal trust: international evidence." Health 03, no. 04 (2011): 206–10. http://dx.doi.org/10.4236/health.2011.34037.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Park, Ju Moon. "Chronic Diseases, Health Status and Health Service Utilization among Koreans." Health 06, no. 16 (2014): 2286–93. http://dx.doi.org/10.4236/health.2014.616263.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ishaq, Sheikh, Harnam Kaur, and Sonam Bhatia. "Clusterin: It’s Implication in Health and Diseases." Annals of Applied Bio-Sciences 4, no. 1 (March 2017): R30—R34. http://dx.doi.org/10.21276/aabs.2017.1402.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Alcarás, Patrícia Arruda de Souza, Bianca Simone Zeigelboim, Maria Cristina Alves Corazza, Débora Lüders, Jair Mendes Marques, and Adriana Bender Moreira de Lacerda. "Vestibular Function Evaluation in Endemic Diseases Combat Agents." Health 13, no. 02 (2021): 144–56. http://dx.doi.org/10.4236/health.2021.132013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chaix, Benjamin, Arthur Guillemassé, Pierre Nectoux, Guillaume Delamon, and Benoît Brouard. "Vik: A Chatbot to Support Patients with Chronic Diseases." Health 12, no. 07 (2020): 804–10. http://dx.doi.org/10.4236/health.2020.127058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Iadiz, Mohammad Ayoub Rigi, Masoud Bamedi, and Sirous Risbaf Fakour. "Periodontal Diseases and Recently Applied Nano-Technology: A Review Article." Health 09, no. 02 (2017): 345–51. http://dx.doi.org/10.4236/health.2017.92024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Habeeba, Shaikh. "Enormous Health Benefits of Nutraceutical in Prevention of Human Health Diseases: A Review." Emerging Trends in Nutraceuticals 1, no. 2 (July 28, 2022): 5–13. http://dx.doi.org/10.18782/2583-4606.106.

Full text
Abstract:
Nutraceutical combines the words "nutrition" and "pharmaceutical." Nutraceuticals, in general, are foods or components of foods that play a vital role in changing and maintaining normal physiological function in healthy individuals. Dietary fiber, prebiotics, probiotics, polyunsaturated fatty acids, antioxidants, and other types of herbal natural foods are used as nutraceuticals. Obesity, cardiovascular disease, cancer, osteoporosis, arthritis, diabetes, cholesterol, and other diseases may be prevented by nutraceuticals. Overall, the term "nutraceutical" has ushered in a new era of medicine and health, in which the food industry has evolved into a research-driven industry. The purpose of this article is to provide knowledge about nutraceuticals and their applications in various diseases.
APA, Harvard, Vancouver, ISO, and other styles
10

England, James J. "Animal health emergency diseases." Veterinary Clinics of North America: Food Animal Practice 18, no. 3 (November 2002): xi—xii. http://dx.doi.org/10.1016/s0749-0720(02)00054-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Health and diseases"

1

Rivers, Caitlin. "Modeling Emerging Infectious Diseases for Public Health Decision Support." Diss., Virginia Tech, 2015. http://hdl.handle.net/10919/52023.

Full text
Abstract:
Emerging infectious diseases (EID) pose a serious threat to global public health. Computational epidemiology is a nascent subfield of public health that can provide insight into an outbreak in advance of traditional methodologies. Research in this dissertation will use fuse nontraditional, publicly available data sources with more traditional epidemiological data to build and parameterize models of emerging infectious diseases. These methods will be applied to avian influenza A (H7N9), Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV), and Ebola virus disease (EVD) outbreaks. This effort will provide quantitative, evidenced-based guidance for policymakers and public health responders to augment public health operations.
Ph. D.
APA, Harvard, Vancouver, ISO, and other styles
2

Mableson, Hayley Elizabeth. "The disease-scape of the new millennium : a review of global health advocacy and its application." Thesis, University of Edinburgh, 2014. http://hdl.handle.net/1842/17855.

Full text
Abstract:
The global disease scape is constantly shifting, influenced by demographic transitions, altering the balance of the burden of infectious and non‐communicable diseases. The epidemiological transitions can be divided into three stages: the first, an increase in infectious disease burden as populations settled, then grew into towns and cities providing conditions for infectious agents to maintain spread; the second transition follows industrialisation, changes in lifestyle, diet and improved sanitation whereby infectious diseases are reduced and non‐communicable disease (NCD) prevalence increases; the third transition describes the re‐emergence of infectious diseases as the AIDS epidemic and other emerging and re‐emerging disease outbreaks lead to an increasing burden of infectious diseases, particularly in developing countries. Analysis of the disease‐scape has been carried out using WHO Global Burden of Disease data and correlation to demographic factors calculated using World Bank Development Indicators. The balance of chronic NCDs and infectious diseases can be represented numerically as the unit rate of infectious to non‐communicable diseases. The rate, which indicates at which end the continuum lies can then be correlated to these demographic development indicators to assess the factors which are influential to the continuum. As the balance of infectious and non‐communicable diseases around the world alters, the focus of the advocacy at the global health level has been examined to assess if the trends follow that of the shifting continuum. This has been carried out through an assessment of the WHO World Health Assembly (WHA) resolutions adopted annually between 1948 and 2013 on the subject of infectious and/or non-communicable diseases. The principle of International health stemmed from the need to contain the international spread of communicable diseases, so it is not surprising that in the first decade of the WHO, 88% of the resolutions adopted for infectious and non‐communicable disease were adopted for infectious diseases. In the latest ten years of the WHO, 72% of the Assembly resolutions for infectious and non‐communicable diseases were focused on infectious diseases; this indicates that while there has been a shift in the balance, the adopted resolutions still focus heavily on infectious diseases. An example of how advocacy can elevate diseases to a higher position on the global health agenda is that of the Neglected Tropical Diseases. Following the Millennium Development Goals, this group of seventeen diseases has been highlighted as being “neglected” in terms of funding, research and political will. A review of the campaign to highlight this shows how global health advocacy can elevate diseases to a prominent position on the global health agenda. With this in mind, the advocacy for a sub‐group of Neglected Zoonotic Diseases has been examined at the WHA level. The results highlight the sporadic nature of support to control these diseases, and that activism for control of some of the major zoonotic diseases remains lacking. Rabies is explored as an example of a disease for which there are recommendations and support at the global level for the control and elimination of the disease, but for which barriers to control exist locally in endemic countries. The advocacy for diseases at the global health level has the possibility to impact the priorities of health care within individual nations. However the advocacy at this level may take time to reflect the changes within the disease‐scape. The impact of such advocacy is also limited by local political will, availability of resources and local cultural implications. Therefore there is a need to ensure that efforts to control diseases are tailored to specific populations and that resources are made available to support the advocacy.
APA, Harvard, Vancouver, ISO, and other styles
3

Rosenberg, Shirit Chaia-Rivka. "Disability, physical activity, health, health status and chronic diseases in adults." Thesis, Teachers College, Columbia University, 2015. http://pqdtopen.proquest.com/#viewpdf?dispub=3704483.

Full text
Abstract:

There is a great deal of concern regarding the levels of physical inactivity in people with disability, which is more prevalent than in the general population. Inactivity in individuals with disabilities can lead to higher rates of chronic diseases and obesity and vice versa. Moreover, disability is increasing in middle-aged adults while decreasing among older adults. This purpose of this dissertation was to: 1) evaluate the prevalence of disability across the lifespan, 2) to examine the relationships between disability (DA), physical activity (PA), and factors associated with them, and 3) to look at the trends in these factors to understand the patterns occurring in middle-aged adults compared with older adults.

Data analyzed for this dissertation were collected as part of the Behavioral Risk Factor Surveillance Survey (BRFSS) conducted between 2003 and 2011. Measures included DA, PA, chronic diseases, sociodemographics, health risk behaviors, and health status.

In our first study, we found that respondents categorized as disabled or functionally limited reported less PA, more chronic diseases, and poorer health behaviors than those categorized as able bodied. There was a higher prevalence of DA in the middle-aged and older adults compared to younger adults. Individuals with lower incomes and those with chronic diseases were more likely to be classified as having a disability compared to individuals with higher incomes and individuals without chronic disease. Our second study showed that middle-aged people were less likely to meet physical activity recommendations compared with older adults. Having a DA and being in poor health were strongly associated with not meeting the PA recommendations. In our third study, we found all the age groups showed an increase in functional limitation and DA over time. Further, among all age groups there was an increase in meeting aerobic recommendations over time. Our studies showed that DA and functional limitation are strongly associated with unhealthy behaviors and chronic diseases and poorer health. Moreover, middle-aged and older adults showed similar results in DA and PA recommendations. Given that physical inactivity has the potential to reduce disability, prevent chronic disease and enhance health, greater public health attention to what is warranted.

APA, Harvard, Vancouver, ISO, and other styles
4

Chocho, Karen. "Hispanic Migrants and Cross-border Disease Control of Arizona's Vaccine Preventable Diseases." Digital Archive @ GSU, 2008. http://digitalarchive.gsu.edu/iph_theses/35.

Full text
Abstract:
BACKGROUND: According to the Centers for Disease Control and Prevention and the National Immunization Program, there is an increase in the re-emergence of past diseases. Even with mandatory vaccination practices in the United States, there are still a number of cases of vaccine-preventable diseases (VPDs) reported yearly. It is speculated that the re-emergence of VPDs is in part due to the increase in international travel as well as the influx of immigrants. One particular group of interest includes the Hispanic migrants coming from Central and South America where some of these diseases are endemic. OBJECTIVE: The purpose of this paper is to determine the extent of VPD cases in the border state of Arizona that may be attributed to Hispanic migrant influx using data from the MMWR: Summary of Notifiable Diseases reports for the United States and the ADHS data from all Arizona counties. RESULTS: Since 1995, rates of hepatitis B and pertussis have been increasing in Arizona and have become higher for non-Hispanics than Hispanics. In 2005, hepatitis B rates were 1.53* for the United States and 7.31* for Arizona; pertussis rates were 8.72* for the United States and 21.60* for Arizona. CONCLUSION: The results of this study's analysis show the need to improve immunization efforts within the non-Hispanic populations in all Arizona counties. (*Per 100,000 population)
APA, Harvard, Vancouver, ISO, and other styles
5

Ding, Hongliu. "Bone Health and Coronary Heart Disease in Postmenopausal Women with Breast Cancer Treated with Tamoxifen: A Dissertation." eScholarship@UMMS, 2008. https://escholarship.umassmed.edu/gsbs_diss/404.

Full text
Abstract:
Breast cancer, osteoporosis, and coronary heart disease (CHD) are three major threats to women’s health. Postmenopausal women with breast cancer are also at high risk for osteoporosis and CHD. Adjuvant tamoxifen therapy is not only an effective treatment for breast cancer, but has been shown to have a beneficial effect on bone and the cardiovascular system. Although tamoxifen has been convincingly demonstrated to be able to preserve bone mineral density (BMD), an unexpected increase of risk of fractures in patients treated with tamoxifen has been reported. The findings of the association of tamoxifen and CHD from previous studies were either borderline or inconsistent. To clarify the discrepancy between BMD and fractures and test the potential beneficial effect of tamoxifen on CHD, I conducted a series of retrospective studies in postmenopausal women with breast cancer who participated in the Cancer Surveillance in HMO Administrative Data (IMPACT study) or the Study of Osteoporotic Fractures (SOF). In patients who participated in the IMPACT study, I demonstrated that the association of tamoxifen and fracture incidence varied at different skeletal sites. Although the association of tamoxifen and fractures in the spine (HR=0.40, 95% CI: 0.09-1.85), wrist (HR=2.49, 95% CI: 0.88-7.06), and total body (HR=0.87, 95% CI: 0.49-1.55) was inconclusive, tamoxifen was associated with an apparent reduction of the risk of hip fracture (HR=0.41, 95% CI: 0.17-1.03, p=0.0565). Importantly, the pattern of observed association of tamoxifen with the risks of fractures among postmenopausal women with breast cancer is consistent with its widely reported preserving effect on bone mineral density. Using SOF data, I found that the association between BMD and fractures in women with breast cancer varied at different skeletal sites, and type of BMD measured. Non-specific BMD was not associated with hip fracture (HR=1.12; 95% CI: 0.78, 1.59). Site-specific BMD was more likely linked with hip fracture (HR=1.43, 95% CI: 0.99, 2.08) while change in BMD did not predict hip fracture (HR=1.05; 95% CI: 0.63, 1.72). The association of spine morphometric fracture with either non-specific or spine-specific BMD was similar (OR=1.40; 95% CI: 1.04, 1.90; OR=1.35, 95% CI: 0.99, 1.85, respectively). Overall, the association of BMD and fracture in elderly women with breast cancer is weak. Only site-specific BMD appears to have a consistently modest association with fractures in the corresponding skeletal sites. In the IMPACT study population, compared to patients without tamoxifen, the overall incidence of CHD in tamoxifen-treated patients was lower (adjusted HR=0.60, 95% CI: 0.40-0.88). For each year of tamoxifen use, there was a statistically significant decrease in the risk of CHD (HR=0.90, 95% CI: 0.82-0.98). Further analyses categorized by length of tamoxifen use showed that an apparent association with a decreased CHD risk was found in patients who received tamoxifen for two to five years (HR=0.54, 95% CI: 0.33-0.86). No association was detected after the discontinuation of tamoxifen therapy. In summary, I detected a possible benefit associated with tamoxifen on fractures in the hip, the most common fracture site. I also found that BMD did not predict osteoporotic fractures well in postmenopausal women with breast cancer. In addition, I demonstrated that tamoxifen was associated with a reduced risk of CHD in postmenopausal women with breast cancer in a dose-dependent manner. An apparent benefit was found in those patients who received tamoxifen therapy for at least two years.
APA, Harvard, Vancouver, ISO, and other styles
6

Xu, Fang, and 徐方. "Self-rated health, chronic diseases and health service utilisation in Hong Kong." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2015. http://hdl.handle.net/10722/212607.

Full text
Abstract:
Introduction Self-rated health (SRH) is a widely used indicator of health service utilisation and reflects self-perceived objective health condition. Poorer non-comparative SRH was shown to be related to higher inpatient and outpatient utilisation in Western and elderly populations. Little is known about how healthcare utilisation relates to SRH in non-Western settings, such as Hong Kong and in adult populations. The association of age- and time- comparative SRH with healthcare utilisation is also unclear. This study aimed to assess the association of three types of SRH (non-, age- and time- comparative SRH) with inpatient and outpatient utilisation in Hong Kong‟s general populaion. Methods Data were derived from 2011 Thematic Household Survey (THS), covering 23,892 non-institutional residents aged 20 and above. The study adopts Andersen‟s Behavioral Model of Health Service Use for the analytical framework. Healthcare utilisation was measured by inpatient use during the past year and outpatient use (including General Outpatient Clinic (GOPC) and Specialist Outpatient Clinic (SOPC)) during the past month, in terms of ever-use and the amount of use (bed-days and number of outpatient visits). SRH was measured with a 5-point Likert Scale: non-comparative SRH from “Excellent” to “Poor”; age- and time- comparative from “much worse” to “much better”. Logistic regression and zero-truncated negative binomial/ Poisson regression were applied to examine the association of SRH and chronic diseases with healthcare utilisation in the public and private sector separately as per the Andersen behavioral model. Results “Fair/ poor” non-comparative SRH was associated with higher inpatient and outpatient utilisation. The association was not significant for hospital bed-days. Similarly, age-comparative SRH was associated with inpatient (except private bed-days) and outpatient utilisation (except the number of SOPC visits). “Worse/ much worse” time-comparative SRH was associated with higher healthcare utilisation, but the relationship was less clear for private hospitalisation. The presence of cancer, cardiovascular diseases, diabetes, lower respiratory diseases, and musculoskeletal diseases were associated with higher healthcare utilisation, with stronger association observed for ever-use than the amount of use. The relationships between musculoskeletal diseases and inpatient utilisation, between cardiovascular diseases and diabetes and the number of private outpatient visits, and between lower respiratory diseases and GOPC utillisation were not significant. Conclusions The present study suggests SRH to be a useful health indicator of health service utilisation. All three SRH measures were associated with health service utilisation and no marked differences were observed between different measures. Poorer SRH were strongly related to higher public inpatient utilisation, with stronger association observed for ever hospitalisation than bed-days. Poorer SRH measures were also related to higher outpatient uilisation in both sectors during the past month. All the selected chronic conditions were related to increased healthcare use. The associations were less clear for hospital bed-days and the private sector. Future studies should focus on the predictive validity of SRH on future healthcare utilisation.
published_or_final_version
Public Health
Master
Master of Philosophy
APA, Harvard, Vancouver, ISO, and other styles
7

MURPHY, CATHRYN LOUISE School of Health Services Management UNSW. "INFECTION CONTROL IN THE AUSTRALIAN HEALTH CARE SETTING." Awarded by:University of New South Wales. School of Health Services Management, 1999. http://handle.unsw.edu.au/1959.4/17600.

Full text
Abstract:
1,708 members of the Australian Infection Control Association were surveyed to describe the practices of Australian infection control practitioners. The study details the methods infection control practitioners use to co-ordinate and measure nosocomial infections as clinical outcomes of Australian infection surveillance and control programs. Administrators' and clinicians' perceptions of the elements and infrastructure of infection surveillance and control programs and the role of the infection control were measured in 316 hospitals in New South Wales, Australia. A literature review found that the development of Australian infection surveillance and control programs is behind that of U.S.A and the United Kingdom. The survey of the infection control practitioners identified that their role and duties varied between facilities as did the time allocated to infection control tasks. The survey of infection control practitioners demonstrated variation in their levels of skill, education and experience. Infection control practitioners' use and application of evidence and associated skills was examined and found to be limited in relation to clinical decision making and policy development. The survey also examined the methods infection control practitioners use to undertake surveillance of nosocomial infections. The methods reported indicated non-standard approaches to surveillance activity. A survey of administrators and clinicians in NSW hospitals was undertaken to identify variation in administrator and clinician perceptions and to describe their level of support for recommended essential infrastructure and criteria for infection surveillance and control programs and the role of the infection control practitioner in accordance with Scheckler's model. The survey indicated divergent views regarding the role of the infection control practitioner and the essential elements of infection surveillance and control programs. The study identified that education of infection control practitioners is necessary to facilitate standard approaches to co-ordinating infection surveillance and control activity. The development of Australian infection surveillance and control programs require a strategic alliance between stakeholders. to define essential elements of infection surveillance and control programs. In addition, the role of the infection control practitioner must be defined before key stakeholders can agree on the minimum skills, qualifications and experience required by an infection control practitioner.
APA, Harvard, Vancouver, ISO, and other styles
8

Das, Debalina. "Waterborne Diseases: Linking Public Health And Watershed Data." Amherst, Mass. : University of Massachusetts Amherst, 2009. http://scholarworks.umass.edu/theses/235/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Faissol, Daniel Mello. "Mathematical modeling of diseases to inform health policy." Diss., Atlanta, Ga. : Georgia Institute of Technology, 2008. http://hdl.handle.net/1853/24690.

Full text
Abstract:
Thesis (Ph.D.)--Industrial and Systems Engineering, Georgia Institute of Technology, 2008.
Committee Chair: Julie Swann; Committee Co-Chair: Paul Griffin; Committee Member: David Goldsman; Committee Member: Pinar Keskinocak; Committee Member: Thomas Gift
APA, Harvard, Vancouver, ISO, and other styles
10

Stevens, Timothy Richard John. "Neutrophil activation in health and connective tissue diseases." Thesis, University of Bath, 1987. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.379167.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Health and diseases"

1

Herpes diseases & your health. [S.l.]: [s.n.], 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hamer, Davidson. Public health and infectious diseases. Oxford, UK: Academic Press, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lyn, Shepherd, Allan Richard 1954-, and Butler Daniel, eds. Health & disease. Hamilton, N.Z: Biozone International, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Richardson, V. C. G. Rabbits: Health, Husbandry and Diseases. Chichester: John Wiley & Sons, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Singh, Prati Pal, ed. Infectious Diseases and Your Health. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-1577-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sharma, Shefali Khanna, ed. Women's Health in Autoimmune Diseases. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-0114-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mahdavinia, Mahboobeh, ed. Health Disparities in Allergic Diseases. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-31222-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Shartava, Tsisana. Health issues, injuries, and diseases. New York: Nova Science Publishers, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Tudor, David C. Pigeon health and disease. Ames, Iowa, USA: Iowa State University Press, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Peikin, Steven R. Gastrointestinal Health. New York: HarperCollins, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Health and diseases"

1

Chuck, Emil T., and Ledric D. Sherman. "Chronic diseases." In Men’s Health, 79–91. Abingdon, Oxon ; New York, NY : Routledge, 2020.: Routledge, 2020. http://dx.doi.org/10.4324/9781351022620-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gott, Marjorie. "Changes for Health." In Western Diseases, 399–417. Totowa, NJ: Humana Press, 1994. http://dx.doi.org/10.1007/978-1-4684-8136-5_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Seifert, Horst S. H. "Contact Diseases." In Tropical Animal Health, 324–440. Dordrecht: Springer Netherlands, 2001. http://dx.doi.org/10.1007/978-94-009-0147-6_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Akinsemolu, Adenike A. "Health and Diseases." In The Principles of Green and Sustainability Science, 111–33. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-2493-6_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Baird, J. Kevin. "Tropical Health and Sustainability." In Infectious Diseases, 309–51. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-5719-0_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Armitage, Keith B., and Robert A. Salata. "Infectious Diseases." In Handbook of Immigrant Health, 349–87. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4899-1936-6_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Armitage, Keith B., and Gary I. Sinclair. "Infectious Diseases." In Handbook of Rural Health, 173–87. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4757-3310-5_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Burman, Kenneth D. "Thyroid Diseases." In Encyclopedia of Women’s Health, 1306–8. Boston, MA: Springer US, 2004. http://dx.doi.org/10.1007/978-0-306-48113-0_436.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Schulz, Thomas R., Georgia Paxton, and Beverley-Ann Biggs. "Infectious Diseases." In Encyclopedia of Immigrant Health, 902–10. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-5659-0_401.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Reddy, Amulya. "Cardiovascular Diseases." In Handbook of Refugee Health, 277–82. Boca Raton: CRC Press, 2021. http://dx.doi.org/10.1201/9780429464874-11-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Health and diseases"

1

"COLLABORATIVE IT PLATFORM FOR RARE DISEASES." In International Conference on Health Informatics. SciTePress - Science and and Technology Publications, 2011. http://dx.doi.org/10.5220/0003171003090314.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Passerini, G., R. Cocci Grifoni, and M. M. Mariani. "Environmental pollutants and human diseases: diagnosis and treatment." In Environmental Health Risk 2005. Southampton, UK: WIT Press, 2005. http://dx.doi.org/10.2495/ehr050441.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Thodika, Nibras, Srujan Janagam, Smitha Kaniyampady, Arkalgud Ramaprasad, Anupama Shetty, and Chetan Singai. "A Model of Cost and Time-Effective Disease Screening for Non-Communicable Diseases in India." In 14th International Conference on Health Informatics. SCITEPRESS - Science and Technology Publications, 2021. http://dx.doi.org/10.5220/0010202103120319.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ishibashi, Y., and I. Nakajima. "The database which creates multilingual web information on preventing infectious diseases." In Proceedings. 6th International Workshop on Enterprise Networking and Computing in Healthcare Industry - Healthcom 2004. IEEE, 2004. http://dx.doi.org/10.1109/health.2004.1324494.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Elkan, Eva-Maria, Ana-Maria Papuc, Roxana Elena Bogdan Goroftei, Elena Ariela Banu, Monica Laura Zlati, Adriana Gabriela Albeanu, and Alina Pleșea Condratovici. "DREAMING AND PARASOMNIAS FROM A CEREBRAL STRUCTURAL VIEW." In The European Conference of Psychiatry and Mental Health "Galatia". Archiv Euromedica, 2023. http://dx.doi.org/10.35630/2022/12/psy.ro.6.

Full text
Abstract:
Introduction: Parasomnias are disorders that may appear during sleep with and/or without dreams. To describe them we must take in account a subjective description by the patient and his relatives. Objective measurement of this phenomenology is made with Polysomnography, Electromyography and Holter EKG. Material and Methods: We searched the recent data about parasomnia in the Medline, Pubmed, Google academic databases as also in classic books and reviews. Results: The clinical picture is various from motor and neurological signs to autonomic signs as also sleep related hallucinations. There are more rare presentations with associated disorders due to excretion and involuntary urinary emission during sleep disorders. Parasomnias are often preceded by a traumatic event for the patient and his family members which can be a head trauma or an infection or an intoxication which can be accompanied by psycho vulnerable events. On the other part parasomnias can be themselves a preamble announcing neurodegenerative diseases like Parkinson disease, Lewy Body Dementia or some synucleopathies. Conclusions: The fluctuations of neurotransmitters (Dopamine, Serotonine or Acetylcholine) due to specific neurologic pathology can lead to particular parasomnias, their evolution corresponding to each impairment. The knowledge of accompanying parasomnias of neurologic disorders like those from Parkinson disease helps manage diseases of neurological patients already known with Parkinson's disease or other neurological diseases, leading to increased quality of life for these patients as a result of specialized intervention.
APA, Harvard, Vancouver, ISO, and other styles
6

Kypuros, Javier A., and Edmundo Marrufo. "A Study of Arterial Vasodilation as a Means of Modulating Wall Shear Stress." In ASME 2002 International Mechanical Engineering Congress and Exposition. ASMEDC, 2002. http://dx.doi.org/10.1115/imece2002-32323.

Full text
Abstract:
Diseases of the heart continue to be the number 1 killer of Americans. In 2001, cardiovascular disease and stroke cost the United States an estimated $298.2 billion [American Heart Association]. Heart disease and related vascular disorders remain focus areas during this decade for the National Institutes of Health (NIH) as reported in Healthy People 2010.
APA, Harvard, Vancouver, ISO, and other styles
7

Syurin, S. A., and A. A. Kovshov. "FORMATION OF OCCUPATIONAL AND NON-OCCUPATIONAL DISEASES IN UNDERGROUND APATITE ORE MINERS." In The 16th «OCCUPATION and HEALTH» Russian National Congress with International Participation (OHRNC-2021). FSBSI “IRIOH”, 2021. http://dx.doi.org/10.31089/978-5-6042929-2-1-2021-1-501-505.

Full text
Abstract:
Abstract. Introduction. Living and working in the Arctic is associated with an increased health risks. The aim of the study was to assess features of non-occupational and occupational disease formation in underground apatite ore miners in the Kola Arctic. Materials and methods. We studied data ofthe periodic medical examination and results of social and hygienic monitoring "Working conditions and occupational morbidity of the population of the Murmansk region". Results. In 2007, 2649 miners were diagnosed with 6778 chronic diseases, of which the most prevalent were diseases of the musculoskeletal system (34.4%) and eye (16.9%). In 2008-2019, 496 occupational diseases were diagnosed for the first time in 290 (10.9%) miners. The risk of developing occupational pathology in drifters exceeded indicators of all other miners, including lumbermen (RR = 1.60; CI 1.07-2.38, р=0,015), operators of a vibratory loading installation (RR = 1.63; CI 0.97-2.74, p=0,041), drillers (RR = 1.57; CI 1.11-2.22, р=0,009) and blasters (RR = 2.13; CI 1.56-2.90, р<0,001). In the structure of occupational diseases, the first places were occupied by vibration disease (19.7%), radiculopathy (19.3%) and deforming osteoarthritis (16.0%). Conclusion. Modernization of ore mining processes and personal protective equipment, as well as a current system of medical measures should include more effective solutions to the problems of preserving health of underground apatite miners in the Kola Polar region.
APA, Harvard, Vancouver, ISO, and other styles
8

Selimović, Jasmina, Velma Pijalović, and Tea Mioković. "EUROPEAN UNION HEALTH SYSTEMS AND RESPONSES TO THE ECONOMIC CRISIS." In HEALTH MANAGEMENT WITH SPECIAL ATTENTION TO CARDIOVASCULAR DISEASES. Akademija nauka i umjetnosti Bosne i Hercegovine, 2018. http://dx.doi.org/10.5644/pi2018.177.03.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ramić-Čatak, Aida. "PUBLIC HEALTH INTERVENTIONS IN MANAGEMENT OF CARDIOVASCULAR DISEASES IN THE FEDERATION OF BOSNIA AND HERZEGOVINA IN THE LIGHT OF WHO HEARTS STANDARDS AS A MODEL OF GOOD PRACTICE." In HEALTH MANAGEMENT WITH SPECIAL ATTENTION TO CARDIOVASCULAR DISEASES. Akademija nauka i umjetnosti Bosne i Hercegovine, 2018. http://dx.doi.org/10.5644/pi2018.177.02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Wang, Jingying. "Lipoproteins and Atherosclerotic Cardiovascular Diseases." In International Conference on Health Big Data and Intelligent Healthcare. SCITEPRESS - Science and Technology Publications, 2022. http://dx.doi.org/10.5220/0011371300003438.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Health and diseases"

1

O’Connell, Joan, Jennifer Rockell, Margaret Reid, Kathleen Harty, Marcelo Perraillon, and Spero Manson. Improving Health Outcomes among Native Americans with Diabetes and Cardiovascular Diseases. Patient-Centered Outcomes Research Institute (PCORI), November 2020. http://dx.doi.org/10.25302/11.2020.ad.13046451.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Border, Peter, and Erin Cullen. The Microbiome and Human Health. Parliamentary Office of Science and Technology, May 2018. http://dx.doi.org/10.58248/pn574.

Full text
Abstract:
This POSTnote examines what is known about the human microbiome and the diseases and conditions linked to it. The note then describes interventions to modify the human microbiome and examines the issues raised by their use and by microbiome research more generally.
APA, Harvard, Vancouver, ISO, and other styles
3

RUSHTON, J., T. BERNARDO, M. BRUCE, C. BELLET, P. TORGERSON, A. P. M. SHAW, M. HERRERO, et al. Global Burden of Animal Diseases – building a community of practice for animal health economics. O.I.E (World Organisation for Animal Health), December 2019. http://dx.doi.org/10.20506/bull.2019.nf.3035.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chauvin, Juan Pablo. Cities and Public Health in Latin America. Inter-American Development Bank, October 2021. http://dx.doi.org/10.18235/0003692.

Full text
Abstract:
This paper presents an overview of how health outcomes vary across cities in Latin America and discusses some of the known drivers of this variation. There are large disparities in outcomes across cities and across neighborhoods of the same city. Because health is closely related to the socioeconomic conditions of individuals, part of the spatial variation reflects residential segregation by income. Local characteristics also have a direct effect on health outcomes, shaping individuals' access to health services and the prevalence of unhealthy lifestyles. In addition, urban environments affect health through natural atmospheric conditions, through local infrastructure in particular water, sanitation, and urban transit and through the presence of urban externalities such as traffic congestion, pollution, crime, and the spread of transmissible diseases. The COVID-19 pandemic illustrates many of these patterns, since the impact of the disease has differed sharply across cities, and much of this variation can be explained by observable local characteristics particularly population, connectivity with other cities and countries, income levels, and residential overcrowding.
APA, Harvard, Vancouver, ISO, and other styles
5

Shey Wiysonge, Charles. Which outreach strategies increase health insurance coverage for vulnerable populations? SUPPORT, 2016. http://dx.doi.org/10.30846/1608142.

Full text
Abstract:
Health insurance refers to a health financing mechanism that involves the pooling of eligible, individual contributions in order to cover all or part of the cost of certain health services for all those who are insured. Health insurance scheme coverage in low-income countries is low, especially among vulnerable populations such as children, the elderly, women, low-income individuals, rural population, racial or ethnic minorities, immigrants, informal sector workers, and people with disability or chronic diseases. Consequently, thousands of vulnerable people suffer and die from preventable and treatable diseases in these settings.
APA, Harvard, Vancouver, ISO, and other styles
6

Barros-Poblete, Marisol, Rodrigo Torres-Castro, Mauricio Henríquez, Anita Guequen, Isabel Blanco, and Carlos Flores. Dysbiosis as a prognostic factor for clinical worsening in chronic respiratory disease: A systematic review and metanalysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0089.

Full text
Abstract:
Review question / Objective: Is dysbiosis a prognostic factor for clinical worsening in patients with chronic respiratory diseases?. Condition being studied: Dysbiosis, defined as changes in the quantitative and qualitative composition of the microbiota. Eligibility criteria: Over 18 years old adult patients with chronic respiratory diseases clinical diagnosis (cystic fibrosis, chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis, interstitial lung disease, sarcoidosis, bronchiectasis, non-CF bronchiectasis, pulmonary hypertension) according to the International Statistical Classification of Diseases and Related Health Problems (ICD) from OMS) and international guidelines of each disease.
APA, Harvard, Vancouver, ISO, and other styles
7

Treadwell, Jonathan R., James T. Reston, Benjamin Rouse, Joann Fontanarosa, Neha Patel, and Nikhil K. Mull. Automated-Entry Patient-Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes. Agency for Healthcare Research and Quality (AHRQ), March 2021. http://dx.doi.org/10.23970/ahrqepctb38.

Full text
Abstract:
Background. Automated-entry consumer devices that collect and transmit patient-generated health data (PGHD) are being evaluated as potential tools to aid in the management of chronic diseases. The need exists to evaluate the evidence regarding consumer PGHD technologies, particularly for devices that have not gone through Food and Drug Administration evaluation. Purpose. To summarize the research related to automated-entry consumer health technologies that provide PGHD for the prevention or management of 11 chronic diseases. Methods. The project scope was determined through discussions with Key Informants. We searched MEDLINE and EMBASE (via EMBASE.com), In-Process MEDLINE and PubMed unique content (via PubMed.gov), and the Cochrane Database of Systematic Reviews for systematic reviews or controlled trials. We also searched ClinicalTrials.gov for ongoing studies. We assessed risk of bias and extracted data on health outcomes, surrogate outcomes, usability, sustainability, cost-effectiveness outcomes (quantifying the tradeoffs between health effects and cost), process outcomes, and other characteristics related to PGHD technologies. For isolated effects on health outcomes, we classified the results in one of four categories: (1) likely no effect, (2) unclear, (3) possible positive effect, or (4) likely positive effect. When we categorized the data as “unclear” based solely on health outcomes, we then examined and classified surrogate outcomes for that particular clinical condition. Findings. We identified 114 unique studies that met inclusion criteria. The largest number of studies addressed patients with hypertension (51 studies) and obesity (43 studies). Eighty-four trials used a single PGHD device, 23 used 2 PGHD devices, and the other 7 used 3 or more PGHD devices. Pedometers, blood pressure (BP) monitors, and scales were commonly used in the same studies. Overall, we found a “possible positive effect” of PGHD interventions on health outcomes for coronary artery disease, heart failure, and asthma. For obesity, we rated the health outcomes as unclear, and the surrogate outcomes (body mass index/weight) as likely no effect. For hypertension, we rated the health outcomes as unclear, and the surrogate outcomes (systolic BP/diastolic BP) as possible positive effect. For cardiac arrhythmias or conduction abnormalities we rated the health outcomes as unclear and the surrogate outcome (time to arrhythmia detection) as likely positive effect. The findings were “unclear” regarding PGHD interventions for diabetes prevention, sleep apnea, stroke, Parkinson’s disease, and chronic obstructive pulmonary disease. Most studies did not report harms related to PGHD interventions; the relatively few harms reported were minor and transient, with event rates usually comparable to harms in the control groups. Few studies reported cost-effectiveness analyses, and only for PGHD interventions for hypertension, coronary artery disease, and chronic obstructive pulmonary disease; the findings were variable across different chronic conditions and devices. Patient adherence to PGHD interventions was highly variable across studies, but patient acceptance/satisfaction and usability was generally fair to good. However, device engineers independently evaluated consumer wearable and handheld BP monitors and considered the user experience to be poor, while their assessment of smartphone-based electrocardiogram monitors found the user experience to be good. Student volunteers involved in device usability testing of the Weight Watchers Online app found it well-designed and relatively easy to use. Implications. Multiple randomized controlled trials (RCTs) have evaluated some PGHD technologies (e.g., pedometers, scales, BP monitors), particularly for obesity and hypertension, but health outcomes were generally underreported. We found evidence suggesting a possible positive effect of PGHD interventions on health outcomes for four chronic conditions. Lack of reporting of health outcomes and insufficient statistical power to assess these outcomes were the main reasons for “unclear” ratings. The majority of studies on PGHD technologies still focus on non-health-related outcomes. Future RCTs should focus on measurement of health outcomes. Furthermore, future RCTs should be designed to isolate the effect of the PGHD intervention from other components in a multicomponent intervention.
APA, Harvard, Vancouver, ISO, and other styles
8

Dunn, Michael A., and Melissa Saul. Framework for Smart Electronic Health Record-Linked Predictive Models to Optimize Care for Complex Digestive Diseases. Fort Belvoir, VA: Defense Technical Information Center, July 2014. http://dx.doi.org/10.21236/ada608042.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Veerappan, Ganesh. Framework for Smart Electronic Health Record - Linked Predictive Models to Optimize Care for Complex Digestive Diseases. Fort Belvoir, VA: Defense Technical Information Center, June 2012. http://dx.doi.org/10.21236/ada568058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Betteridge, John D. Framework for Smart Electronic Health Record- Linked Predictive Models to Optimize Care for Complex Digestive Diseases. Fort Belvoir, VA: Defense Technical Information Center, August 2013. http://dx.doi.org/10.21236/ada588419.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Health and diseases' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography